EREBAGEN LTD

Company number 12537588 · Monitor this company

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£216,957

Balance sheet as at 2026-03-31

View full accounts →

Overview

Company type: Private Limited Company
Incorporated: 2020-03-30
Employees: 3 (2026 accounts)
Registered office: Cie Building Begbroke Hill, Yarnton, Kidlington, Oxfordshire, England, OX5 1PF
Postcode: OX5 1PF
Capital: 1 GBP
Accounts category: Micro

Accounts

Last made up to: 2026-03-31
Next due by: 2027-12-31
Financial year end: 31 March

Confirmation statement

Last statement dated: 2026-03-29
Next due by: 2027-04-12

View filing history →

Nature of business (SIC)

72110 Research and experimental development on biotechnology
72190 Other research and experimental development on natural sciences and engineering

Officers 5 current

Bernd, Dr GERHARTZ Director

Appointed 2024-06-01

David, Dr WILLIAMS Director

Appointed 2024-01-24

Fiona Angela Olinda, Dr MARSTON Director

Appointed 2022-04-01

Douglas Mark ROBERTS Director

Appointed 2020-03-30

Gregory Leonard, Dr CHALLIS Director

Appointed 2020-03-30

View all officers and resignations →

Previous registered addresses 1

Address	Changed on
46 WATERLOO STREET, LEAMINGTON SPA, CV31 1JU, ENGLAND	2020-08-27

At this address

20

companies are registered at this postcode →

Competitors Oxford

1. BRACCO HORIZONS LIMITED

£526,148,027
2. GREY WOLF THERAPEUTICS LIMITED

£86,763,972
3. BLUE EARTH THERAPEUTICS LIMITED

£55,488,752
4. MOA TECHNOLOGY LIMITED

£48,156,558
5. PATHIOS THERAPEUTICS LIMITED

£45,729,623

This company ranks 58 among research and experimental development on biotechnology in Oxford.

Full league table →

The class of 2020

41%

of the 596 companies in this sector incorporated in 2020 are still active today; 54% have since been dissolved.

A fact about the year, not a forecast for this company.